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Purpose: To test the hypothesis that ischemia nd reperfusion i jury may contribute to the 
cause or nonlaealing of venous ulcers, the effects of postural change on the microcircula- 
tion of ulcers and on levels of known mediators of reperfusion injury in their venous 
effluent were studied. 
Methods: A standard protocol of stabilization (20 minutes), limb dependency (1 hour), 
and reelevation (2 hours) was used in 10 patients with venous leg ulcers as proven by 
clinical history, examination, ankle-brachial pressure index, and fight reflective rheogra- 
phy. Superficial blood flow in and around ulcers was repeatedly examined with a new 
laser-Doppler scanning technique. Blood samples from the saphenous vein or a tributary 
adjacent o the ulcer before dependency and at 0, 10, 30, 60, and 120 minutes after 
reelevation were analyzed for tumor necrosis factor-0t, interleukin (IL)-IRA, IL- I~,  
IL-6, platelet-activating factor, thromboxane B2, leukotriene B4, and P-selectin. 
Results: Scans showed a consistent pattern of high ulcer blood flow, which decreased on 
dependency (p < 0.05) and then returned to baseline levels on reelevation and (in 7 of 10) 
eventually exceeded initial values. Mediator assays howed that levels of platelet-activat- 
hag factor, IL-1RA, and IL-6 were significantly higher in resting ulcer venous effluent 
than in systemic venous samples; the reverse was true for P-selectin. There was no 
statistically significant change in effluent concentration of any mediator as a function of 
posture, ulcer size, or healing. 
Conclusions: Postural vasoregulation causes relative ischemia nd reperfusion in venous 
leg ulcers. However, this is not associated with changes in release of mediators known to 
be related to reperfusion i jury in internal organs. (J Vasc Surg 1997;25:647-53.) 
The mechanisms that initiate and cause persis- 
tence of venous ulcers remain uncertain. Venous 
hypertension unrelieved by calf pumping and per- 
haps exacerbated by reflux through incompetent per- 
forating veins is clearly the ultimate cause. However, 
the relationship between this physiological distur- 
bance and other pathologic findings is unclear. Re- 
duced oxygen extraction, perivascular fibrin cuffing, 
and trapping of cytokines are all observable features 
of the syndrome 1-3 but do not completely explain its 
pathogenesis. The white cell hypothesis suggests that 
leukocyte adherence to a hypertensive microvascula- 
ture may occlude it or induce production of agents 
that cause tissue damage. 4 Reactive oxygen species 
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are obvious candidates for this role, because they are 
produced by sequestered leukocytes under condi- 
tions ofischemia nd reperfusion and are thought o 
be associated with fibrosis, s
It has been suggested that ischemia-reperfusion 
injury is a significant factor in the genesis of venous 
ulcers or their failure to heal. 6-8 This hypothesis re- 
quires that (1) the dermal microcirculation of the 
lower legs of patients with venous hypertension is
subjected to repeated and severe pisodes ofischemia 
and reperfusion and (2) biologically significant 
amounts of free radicals are generated at this site in 
consequence. 
Several groups have attempted to examine these 
phenomena. Whiston et al.9 have shown that neutro- 
phil leukocytes isolated from the venous effluent of 
patients with chronic venous disease respond to the 
chemotactic peptide fMLP by producing a stronger 
chemiluminescence than neutrophils similarly iso- 
lated from patients in a normal control group. Al- 
though this finding suggests that these cells are acti- 
vated to produce free radicals, it does not prove that 
they do so within the skin itself. Edwards et al.lo 
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Fig. 1. Experimental design. 
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found plasma glutathione peroxidase, a naturally oc- 
curring free radical scavenger, and its cofactor, sele- 
nium, were reduced in biopsy specimens of venous 
ulcer tissue, which they interpret as evidence of oxi- 
dative stress and hence of free radical generation 
caused by ischemia-reperfusion injury. Neither these 
nor any other study have directly shown either that 
severe episodic ischemia and reperfusion occurs in 
venous ulceration or that free radicals (if generated) 
arise from this cause rather than as a result of infec- 
tion or cytokine release. 
Direct measurement of "free radicals" in blood 
and tissue remains problematic. 11However, several 
cytokines and other mediators are also released as a 
result of and contribute to reperfusion stress in the 
heart, kidney, central nervous ystem, or gut. These 
include interleukin (IL)-6,12 tumor necrosis factor- 
c~, 13 IL-II3,14 IL-1RA, is leukotriene B4,16 and 
thromboxane B217 and the adhesion molecule, P- 
selectin, is We have therefore measured the release of 
these agents into tributaries of the saphenous vein 
adjacent to venous ulcers during a standard protocol 
of limb dependency and reelevation. During the 
same protocol we also examined alterations in super- 
ficial blood flow in and around these wounds by 
scanning laser-Doppler perfusion imaging (SLDI). 
Our results show that the veno-arteriolar reflex 
does lead to a reduction of superficial blood flow in 
and around ulcers during dependency and its slow 
restoration on reelevation. However, we fotmd no 
correlation between mediator release and either limb 
position or blood flow. We are unable to rule out a 
contribution of free radical production to venous 
ulceration. However, if they play a significant role, 
our experiment suggests that their production is not 
a result of ischemia nd reperfusion. 
METHODS 
With ethical committee approval and informed 
consent, 10 patients with leg ulcers (mean age, 67.8 
years; range, 56 to 80 years) without significant arte- 
rial impairment, diabetes, or rheumatoid arthritis 
were entered into the study. All patients had venous 
ulceration over a period of 7 months to 30 years; 
ulcers ranged in size from 0.3 to 127.6 cm 2 (mean, 
16.1 cm2). All had ankle-brachial systolic blood pres- 
sure ratios >0.9. Light reflective rheography showed 
a recovery time of less than 20 seconds (normal value 
>25 seconds), proving the presence of venous insuf- 
ficiency. Light reflective rheography in conjunction 
with occlusion of the superficial veins above and 
below the knee by tourniquet at 70 and 40 mm Hg, 
respectively, with a wide blood pressure cuff indi- 
cated that all patients but one had problems in the 
deep venous system, or perforators. At and after 
these investigations all patients were undergoing 
therapy with a hydrocolloid or simple nonadherent 
primary dressing and compression bandaging. 
A 16-gauge siliconized cannula was inserted in 
the long saphenous vein or a tributary at a site as near 
to the ulcer as possible. Blood flow was allowed to 
stabilize with the leg horizontal for 20 minutes. 
Thereafter, systemic (arm) and local (leg) blood sam- 
ples were obtained without occlusion. The leg was 
then lowered to dependency for 1 hour. At the end 
of 1 hour the leg was reelevated to the horizontal, 
and sequential blood samples were taken immedi- 
ately and at 10, 30, 60, and 120 minutes (Fig. 1). 
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Perfusion imaging by SLDI. The technique 
has been described in detail elsewhere. 19It was cho- 
sen in preference to other methods for evaluating 
superficial perfusion to circumvent he substantial 
point-to-point heterogeneity in skin blood flow. It 
has been shown to compare well with conventional 
single site laser-Doppler monitoring and with ther- 
mography 2°and has been used to observe changes in 
experimental skin wounds and island flaps. 2x,22 
In brief, the system comprises a laser, a light path 
determined by mirrors moved by step-motors, an 
optical detector system, and a computer with color 
monitor. The scanner consists of a low-power heli- 
um-neon laser, which sequentially illuminates up to 
4096 measurement si es on the surface of  the tissue 
under study, covering an area of  approximately 144 
cm 2 in approximately 5 minutes. At each measure- 
ment point the laser light penetrates the epidermis to 
a depth of a few hundred microns, where the light is 
Doppler-shifted and partially backscattered by mov- 
ing blood cells. A fraction of the backscattered light 
is received by a photodetector in the scanner head 
and is converted to an electrical signal proportional 
to the concentration and the velocity of the blood 
cells in the sampling volume. A color-coded perfu- 
sion image of  the underlying tissue is generated for 
display and analysis. Average perfusion and the asso- 
ciated standard eviation within regions of interest 
may be calculated. SLDI values can also be retrieved 
numerically and are expressed in volts. 
During the study room temperature was kept 
between 21 ° C and 25 ° C. The laser beam was orien- 
tated perpendicular to the skin surface, with the scan- 
ning head at a distance of 14 cm. Small black paper 
markers were applied to the margins of  ulcers to serve 
as fiduciary marks during analysis. Laser Doppler 
scans of the ulcer proper and surrounding skin were 
performed at the leg horizontal for 20 minutes and 
were repeated immediately before reelevation and at 
20, 60, and 120 minutes thereafter (Fig. 1). 
Scans were analyzed as follows: the value for the 
ulcer proper was determined for 25 wound-central 
pixels and the value for the surrounding intact skin 
on a minimum of 25 sites to give the mean and 
standard eviation of  perfusion values for the rele- 
vant regions of interest. 
Mediator measurements 
Platelet activating factor (PAF). A 2 ml blood 
sample was taken into a polypropylene tube contain- 
ing 6 ml of  ice-cold methanol and was immediately 
vortexed. Samples were then centrifuged at 2500g 
for 20 minutes at 4 ° C. Two 2 ml aliquots of  the 
methanol supernatant were withdrawn and stored at 
-20  ° C until measurement was performed by radio- 
immunoassay. 
Tumor  necrosis factor-or, IL-11], IL-1RA, 
IL-6, P-Selectin. For determination of these cyto- 
kines an 8 ml blood sample was taken into a plain 
tube, allowed to clot for at least 3 hours in the 
refrigerator, and then centrifuged at 2500 rpm 
(1500g) for 10 minutes at 4 ° C. The serum was 
aliquoted into two polypropylene tubes and frozen 
at -20°C until assay. Tumor necrosis factor-s, 
IL-I[3, IL-1RA, IL-6, and P-Selectin in human 
serum were determined with "sandwich" enzyme 
immunoassay techniques (Quantikine immunoas- 
say, R&D Systems, Minneapolis, Minn.). Concen- 
trations were read with reference to a standard 
curve constructed with a known amount of  the 
mediator of  interest produced by recombinant 
technology. 
Thromboxane B2 and leukotriene B4. A 5 ml 
blood sample was taken into an ethylenediamine 
tetraacetic acid tube containing 25 Ixl of 0.04 mol /L  
indomethacin (50 mg dissolved in 3.5 ml of absolute 
ethanol). The tube was vortexed and centrifuged at 
2500 rpm (1500g) for 10 minutes at 4 ° C to separate 
the plasma, which was collected into two polypro- 
pylene tubes. Aliquots were then frozen a t -20  ° C 
until assay. Thromboxane B2 in plasma was mea- 
sured with enzyme-linked immunosorbent assay 
(Elisa Technologies, Lexington, Ky.) and leukotri- 
ene B4 with a high-sensitivity leukotriene B4 enzyme 
immunoassay (Amersham International, Amersham, 
U.K.). 
Statistical analysis. Because data could not be 
assumed to be normally distributed, Wilcoxon's 
signed rank test was used. A p value of 0.05 or less 
was considered significant. 
RESULTS 
Perfusion imaging 
A representative s ries of  SLDI images is shown 
in Fig. 2. The mean perfusion values in ulcers proper 
were greater than those in intact surrounding skin at 
all time points (Fig. 3). The differences are statisti- 
cally significant (p < 0.05). There was no correlation 
between ulcer area and perfusion values measured 
within or around them. Postural change altered the 
superficial blood flow in both the ulcer proper and in 
surrounding skin. When the leg position was 
changed from supine to dependency, the SLDI per- 
fusion values decreased significantly (p < 0.05). After 
the leg reelevation to the supine position, blood flow 
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Fig. 2. Representative ulcer and serial SLDI scans performed at a, 20-minute horizontal; b, 
1-hour dependency; c, 20-minute reelevation; d, 1-hour reelevation; e, 2-hour reelevation; f,
color coding of scans. 
returned slowly to and often eventually exceeded 
baseline levels• In 4 o f  10 cases ulcer perfusion was 
still less than initial values at 20 minutes. The same 
was true of  adjacent normal skin in 5 of  10 cases. At 
the 1- and 2-hour time points both ulcer and normal 
skin blood flow exceeded resting values in 7 o f  10 
cases. Thus relative ischemia induced by dependency 
was followed by hyperperfusion at some point during 
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Fig. 3. Mean SLDI perfusion values (+SEM). 
recovery in most of the patients. The observation 
period of reelevation was not extended beyond 2 
hours, although further increases in perfusion are 
possible after this time, because values were still ris- 
ing in 7 of 10 patients. 
Cytokines and mediators (Fig. 4) 
PAF. In the supine position PAl= values in ve- 
nous blood obtained from the leg were significantly 
higher than those from arms (p < 0.05). 
IL-1RA. Ten out of 10 samples howed greater 
IL-1RA values in the leg in the supine position than 
in the arm (p < 0.01). Compared with the supine 
position, all IL-1RA values were decreased at 2-hour 
reelevation (p < 0.01). 
IL-6. Supine leg values were higher than those 
for supine arm (p < 0.05). Although 8 of 10 cases 
had greater IL-6 values after reelevation, the differ- 
ences between the supine leg values and the postel- 
evation values (10 minutes and 30 minutes) were not 
significant. 
P-selectin. The supine P-selectin values for arms 
were greater than those for legs in all cases (p < 
0.01). The differences between the supine leg values 
and the reelevation values were not significant. 
Tumor necrosis factor-a, IL-lJ3, TxB2, and 
leukotriene B4. Only two patients had detectable 
levels of tumor necrosis factor-~. There was no de- 
tectable IL-lf3 levels in any case. The differences in 
TxB2 values and leukotriene B4 between different 
sampling time points were not significant. 
Correlation of  mediators, blood flow, and 
clinical outcome 
No statistically significant association was found 
between baseline levels of any mediator or changes in 
their concentration in venous blood with either 
blood flow, ulcer size, or outcome of treatment. 
However, basal PAF levels were >580 pg/ml  in four 
of five patients whose ulcers healed within the treat- 
ment period, whereas in all nonhealing patients PAF 
was <400 pg/ml. After dependency and 2 hours' 
reelevation, PAF levels in all five healing patients 
were lower than at baseline, whereas in three of five 
with persistent ulceration levels were elevated com- 
pared with initial values. 
Correlations were sought between changes in 
perfusion and clinical outcome. Although study 
numbers were too small for statistical significance, 
it was noted that resting ulcer LDI values were 
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Fig. 4. Mediators in venous effluent under study, a, PAF; b, IL-6; c, IL-1RA; d, P-selectin. 
>2.2 V in four of  five patients who went on to 
heal, whereas they were less than this value in four 
of  five who did not. There was no correlation 
between treatment and healing in this small num- 
ber of  patients. 
D ISCUSSION 
The change of  limb position from the horizontal 
to dependency is known to reduce blood flow in 
normal skin and venous  u lcers  23 via the veno-arterio- 
lar reflex. However, no study has been performed to 
determine the events that follow reelevation. We 
found that reperfusion was slow and commonly re- 
suited in an "overshoot" above initial values, often an 
hour or more after reelevation. 
The relationship between levels of mediators in 
effluent venous blood and ulcer tissue is uncertain. 
However, we chose to measure ffluent venous blood 
because we wished to study changes over time in 
production or release of  these agents. Repeated bi- 
opsy is impractical and is likely to alter wound perfu- 
sion, impeding the other measurements to be made. 
Furthermore truly quantitative techniques for tissue 
do not exist for many of  these mediators, which may 
also show heterogeneity of distribution within 
chronic wounds. This study showed that PAF, IL- 
1RA, and IL-6 values in venous blood draining ul- 
cers at rest were significantly greater than those 
found in the arm, whereas the reverse was true for 
P-selectin. Similar systemic alterations are found in 
reperfusion i jury, septic shock, and multiorgan fail- 
ure. 13'17'24'2s However, alterations in posture and 
blood flow caused no consistent changes in any of  
the mediators tudied here. Thus although relative 
ischemia and slow reperfusion clearly occurred and 
the venous effluent contains high concentration of  
mediators associated with reperfusion i jury, we are 
left with the conundrum that there appears to be no 
correlation between the two phenomena. 
Unlike the situation of  arterial occlusion and re- 
lease, ischemia caused by dependency in venous hy- 
pertension is relatively mild, and reperfusion occurs 
far more slowly. It is possible that the rate and extent 
of  reperfusion are critical determinants of the gener- 
ation of  free radicals, secondary mediators, and tissue 
damage. Thus if reactive oxygen species are gener- 
ated sufficiently slowly, the buffeting capacity of  ad- 
jacent issue may be adequate to prevent injury. 
Our results upport he generation of  free radicals 
within venous ulcers in response to stimuli other 
than reperfusion. In particular, the demands of  bac- 
terial killing and debridement can induce free radical 
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production by macrophages and neutrophils via cy- 
tokine-mediated pathways. We are currently investi- 
gating the utility of elcctron spin resonance of red 
cell membranes in venous blood as a measure of free 
radical damage to address these questions more di- 
rectly. 
The trend toward an association between higher 
levels of PAF in draining venous blood and healing 
also warrants further study. PAF has been shown to 
promote angiogenesis 26 and macrophage activa- 
tion 27 and to accelerate gain in tensile strength in 
experimental incisional skin wounds. 2s 
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